Furthermore, expression of NaV1.5 is increased in several cancers, including ovarian [260], colon [261], and breast cancers [262], therefore its inhibition significantly impairs in vitro and in vivo invasion of breast cancer cells [262]. This evidence concerns the gene SCN5A and breast carcinoma.